anti-Vasohibin 2 (VASH2) Antikörper

Angiogenesis inhibitor. Zusätzlich bieten wir Ihnen Vasohibin 2 Proteine (2) und und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
VASH2 79805 Q86V25
VASH2 226841 Q8C5G2
VASH2 498309  
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-Vasohibin 2 Antikörper auf antikoerper-online.de

Showing 10 out of 43 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Lieferzeit Preis Details
Human Kaninchen Unkonjugiert FACS, WB VASH2 Antibody (C-term) (ABIN657877) western blot analysis in mouse Neuro-2a cell line lysates (35 µg/lane). This demonstrates the VASH2 antibody detected the VASH2 protein (arrow). 400 μL 10 bis 11 Tage
$385.00
Details
Human Kaninchen Unkonjugiert ELISA, WB 200 μL 12 bis 14 Tage
$438.90
Details
Human Kaninchen Unkonjugiert FACS, ELISA, WB   200 μL 11 bis 16 Tage
$658.43
Details
Human Kaninchen PE FACS, ELISA, WB   200 μL 11 bis 14 Tage
$1,101.83
Details
Human Kaninchen HRP FACS, ELISA, WB   200 μL 11 bis 14 Tage
$1,101.83
Details
Human Kaninchen Alkaline Phosphatase (AP) FACS, ELISA, WB   200 μL 11 bis 14 Tage
$1,101.83
Details
Human Kaninchen FITC FACS, ELISA, WB   200 μL 11 bis 14 Tage
$1,101.83
Details
Human Kaninchen APC FACS, ELISA, WB   200 μL 11 bis 14 Tage
$1,101.83
Details
Human Kaninchen Biotin FACS, ELISA, WB   200 μL 11 bis 14 Tage
$1,101.83
Details
Human Kaninchen Unkonjugiert FACS, WB   400 μL 11 bis 14 Tage
$493.17
Details

Weitere Antikörper gegen Vasohibin 2 Interaktionspartner

Human Vasohibin 2 (VASH2) Interaktionspartner

  1. VASH2 promotes tumor angiogenesis as a result of paracrine activity and evasion of tumor immunity as a result of altered gene expression in pancreatic ductal adenocarcinoma cells.

  2. VASH2 may promote drug resistance of breast cancer cells through regulating ABCG2 via the AKT signaling pathway.

  3. These results suggest that VASH-2 could play an important role in the pathogenesis of renal diseases, and that VASH-2 is closely associated with hypertension and impaired glucose tolerance.

  4. VASH1 and VASH2 but not SVBP alone, increased detyrosination of -tubulin, and purified vasohibins removed the C-terminal tyrosine of -tubulin.

  5. These results suggest that VASH2 plays an important role in gastric tumor progression via the accumulation of cancer-associated fibroblasts

  6. The present study suggests a protective effect of miR-200b/c on high glucose induced human retinal microvascular endothelial cell line dysfunction by inhibiting VASH2.

  7. VASH2 expression is positively correlated with FGF2 expression and promotes angiogenesis in human luminal breast cancer by transcriptional activation of fibroblast growth factor 2 through non-paracrine mechanisms.

  8. These data suggest that VASH2 reduces the chemosensitivity to gemcitabine in pancreatic cancer cells via JUN-dependent transactivation of RRM2.

  9. identified a novel UPS regulatory system in which essential domain architecture (VASH-PS) of VASHs, comprising regions VASH191-180 and VASH280-169 , regulate the cytosolic punctate structure formation in the absence of SVBP.

  10. The results indicate that VASH2 played a significant role in the epithelial-mesenchymal transition by modulating the TGF-beta signaling.

  11. to the best of our knowledge, these results are the first clinical data indicating that nuclear VASH2, but not cytoplasmic VASH2, promotes cell proliferation by driving the cell cycle from the G0/G1 to S phase.

  12. MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma

  13. Suggest that overexpression of VASH2 in pancreatic ductal adenocarcinoma accelerated the pace of tumor development toward a more serious malignant phenotype and was associated with a poor clinical outcome.

  14. VASH1 and VASH2 showed distinctive localization and opposing function on the fetoplacental vascularization.

  15. VASH2 overexpression downregulated wild-type p53.

  16. VASH2 expressed in serous ovarian carcinoma cells promoted tumor growth and peritoneal dissemination by promoting angiogenesis.

  17. This is the first study to report differences in the intracellular localization of the VASH2 protein and, hence, a new research direction on the study of VASH2

  18. vasohibin-1 and vasohibin-2 mRNA are expressed in gastric cancer cells and in tumor-associated macrophages (TAMs), and their expressions are altered by hypoxia.

  19. VASH2 contributes to the angiogenesis in hepatocellular carcinoma via an Small vasohibin binding protein-mediated paracrine mechanism.

  20. Data suggest that VASH1 is expressed in vascular endothelium to terminate angiogenesis; VASH2 appears to be expressed in other cells (primarily mononuclear leukocytes) to promote angiogenesis. [REVIEW]

Mouse (Murine) Vasohibin 2 (VASH2) Interaktionspartner

  1. High VASH2 expression is associated with diabetes-induced glomerular alterations, particularly impaired filtration barrier and mesangial expansion.

  2. These results suggest that VASH2 plays an important role in gastric tumor progression via the accumulation of cancer-associated fibroblasts

  3. VASH2 drives breast cancer cells to undergo EMT by activation of the TGFbeta1 pathway and hypoxia dependent repression GATA3-ESR1 pathway, leading to cancer metastasis.

  4. VASH1 and VASH2 showed distinctive localization and opposing function on the fetoplacental vascularization.

  5. VASH2 may modulate the onset of tumors in the gastrointestinal tract by regulating tumor angiogenesis.

  6. Loss of vasohibin-2 is associated with deficient angiogenesis in the termination sprouting front of endothelial cells.

Vasohibin 2 (VASH2) Antigen-Profil

Protein Überblick

Angiogenesis inhibitor. Inhibits network formation by endothelial cells.

Genbezeichner und Symbole assoziert mit anti-Vasohibin 2 (VASH2) Antikörper

  • vasohibin 2 (VASH2) Antikörper
  • vasohibin 2 (vash2) Antikörper
  • vasohibin 2 (Vash2) Antikörper
  • B130052G07Rik Antikörper
  • RGD1564105 Antikörper
  • RP11-275G3.1 Antikörper
  • si:ch211-147d7.1 Antikörper

Bezeichner auf Proteinebene für anti-Vasohibin 2 (VASH2) Antikörper

vasohibin 2 , vasohibin-2 , vasohibin-like , vasohibin-2-like , vasohibin-like protein

GENE ID SPEZIES
421364 Gallus gallus
469677 Pan troglodytes
539085 Bos taurus
562668 Danio rerio
608015 Canis lupus familiaris
709924 Macaca mulatta
100406551 Callithrix jacchus
100441602 Pongo abelii
100481580 Ailuropoda melanoleuca
100022988 Monodelphis domestica
100525601 Sus scrofa
100605439 Nomascus leucogenys
79805 Homo sapiens
226841 Mus musculus
498309 Rattus norvegicus
Ausgewählte Anbieter für anti-Vasohibin 2 (VASH2) Antikörper
Haben Sie etwas anderes gesucht?